Interesting update seems to be working still.
- Some appear to be showing an increase in function. I wonder what the take is on this or is it just 'noise' in the somewhat subjective measurement.
- P rating of pro-act vs traditional placebo group. While the P rating is statistically significant when comparing to pro-act, I wonder what fudge factor is built in to account for it not quite the same as placebo. I feel there is a gremlin hiding in this somewhere but perhaps it's just my sceptical curiosity. Does taking it to the most conservative numbers, somewhat account for this in the best way possible (because we will never know how placebo will actually work until the trial).
- Forums
- ASX - By Stock
- NUZ
- Ann: Positive Interim Study Results from OLE Study in ALS
NUZ
neurizon therapeutics limited
Add to My Watchlist
3.13%
!
16.5¢

Ann: Positive Interim Study Results from OLE Study in ALS, page-6
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
16.5¢ |
Change
0.005(3.13%) |
Mkt cap ! $81.23M |
Open | High | Low | Value | Volume |
16.5¢ | 16.5¢ | 15.5¢ | $98.39K | 606.6K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 3600 | 16.0¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
16.5¢ | 86392 | 5 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 3600 | 0.160 |
8 | 223908 | 0.155 |
7 | 122047 | 0.150 |
2 | 303482 | 0.145 |
1 | 7135 | 0.140 |
Price($) | Vol. | No. |
---|---|---|
0.165 | 86392 | 5 |
0.175 | 10000 | 1 |
0.180 | 71000 | 3 |
0.185 | 109375 | 3 |
0.190 | 24925 | 2 |
Last trade - 15.45pm 11/07/2025 (20 minute delay) ? |
Featured News
NUZ (ASX) Chart |
The Watchlist
VMM
VIRIDIS MINING AND MINERALS LIMITED
Rafael Moreno, CEO
Rafael Moreno
CEO
SPONSORED BY The Market Online